Meta has now rolled out the "Build Your 2026 Algorithm" feature for Instagram Reels to allow users use it to personalize their feeds. Instagram Reels 'Build Your 2026 Algorithm' Now Live After a test ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Building owners and property managers will no longer be able to use algorithm-based software to artificially inflate New Yorkers’ rents as a result of a bill signed into law by Gov. Kathy Hochul on ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Abstract: This paper focuses mainly on the time and space complexity computation of the Tower of Hanoi, this mathematical game or puzzle is a well-known problem for its exponential time consumption, ...

The reliable engineering of quantum states, particularly those involving several particles, is central to the development of various quantum technologies, including quantum computers, sensors and ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical success. The recent cull of programs has further undermined investor ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...